Analytical Data
-
Gene name
LCT
- Application
-
Alternative Names
LAC; LPH; LPH1; Lactose-Phlorizin Hydrolase
-
Species
Rat
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q02401
-
Expression Region
Ala33~Ala291
-
Molecular Weight
32kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LCT (Lactose Carrier Transporter) recombinant proteins have garnered significant attention in biological and pharmaceutical research due to their crucial role in lactose metabolism and potential therapeutic applications. Lactose intolerance affects a substantial portion of the global population, leading to digestive issues upon consumption of dairy products. Consequently, understanding the function of LCT at a molecular level paves the way for developing novel treatments and interventions for lactose intolerance and related disorders. Researchers have focused on the recombinant expression of LCT proteins in various host systems to elucidate their structure, transport mechanisms, and interactions with other biomolecules. By leveraging techniques such as molecular cloning, protein engineering, and biochemical assays, scientists aim to enhance the functional properties of LCT proteins, leading to innovations in drug delivery and enzyme replacement therapies. The study of LCT recombinant proteins not only contributes to our comprehension of lactose metabolism but also holds promise for enhancing food science, nutrition, and the development of functional foods tailored for individuals with lactose intolerance. As research progresses, the potential applications of LCT recombinant proteins in biotechnology and healthcare continue to expand, highlighting their significance in addressing dietary challenges and improving quality of life for those affected by lactose malabsorption.
